{"organizations": [], "uuid": "2bbb7939a08098f5869b43c68df9e68687a37cc9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180420.html", "section_title": "Archive News &amp; Video for Friday, 20 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/shire-ma-takeda-pharma/takeda-weighs-raising-shire-bid-to-more-than-47-stg-share-sources-idUSL1N1RX0LS", "country": "US", "domain_rank": 408, "title": "Takeda weighs raising Shire bid to more than 47 stg/share-sources", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.002, "site_type": "news", "published": "2018-04-20T21:20:00.000+03:00", "replies_count": 0, "uuid": "2bbb7939a08098f5869b43c68df9e68687a37cc9"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/shire-ma-takeda-pharma/takeda-weighs-raising-shire-bid-to-more-than-47-stg-share-sources-idUSL1N1RX0LS", "ord_in_thread": 0, "title": "Takeda weighs raising Shire bid to more than 47 stg/share-sources", "locations": [], "entities": {"persons": [{"name": "takeda", "sentiment": "negative"}, {"name": "chizu nomiyama", "sentiment": "none"}, {"name": "shire", "sentiment": "none"}, {"name": "ben martin", "sentiment": "none"}], "locations": [{"name": "shire", "sentiment": "none"}, {"name": "japan", "sentiment": "none"}, {"name": "london", "sentiment": "none"}], "organizations": [{"name": "takeda pharmaceutical co ltd", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "shire", "sentiment": "none"}, {"name": "shire plc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 20 (Reuters) - Japan’s Takeda Pharmaceutical Co Ltd is considering raising its cash-and-stock bid for London-listed drug maker Shire Plc to approximately 47 pounds ($66) per share or more, people familiar with the matter said on Friday.\nTakeda is still finalizing its latest offer, the sources said, asking not to be identified because the deliberations are confidential. On Thursday, the companies disclosed that Shire had rejected Takeda’s third indicative bid of 46.50 pounds per share.\nTakeda and Shire did not immediately respond to requests for comment. (Reporting by Ben Martin in London Editing by Chizu Nomiyama)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-20T21:20:00.000+03:00", "crawled": "2018-04-21T18:13:08.002+03:00", "highlightTitle": ""}